Progress of Application of Shenfukang II Capsule in Iga Nephropathy

Banghui Jiang; Jian Shi

doi:10.23977/medcm.2023.050706

Progress of Application of Shenfukang II Capsule in Iga Nephropathy

Download as PDF

DOI: 10.23977/medcm.2023.050706 | Downloads: 31 | Views: 362

Author(s)

Banghui Jiang ¹, Jian Shi ²

Affiliation(s)

¹ Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
² Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, 710003, China

Corresponding Author

Jian Shi

ABSTRACT

In this paper, Shenfukang II capsule was used to investigate the treatment of IgA nephropathy by literature review, mainly from three aspects: theoretical research, experimental research and clinical research, and obtained certain clinical efficacy, with fewer side effects and drug conjunctibles. Long-term application can reduce toxicity and increase efficacy of IgA nephropathy patients, and delay the deterioration of IgA nephropathy in the later stage.The efficacy of improving long-term prognosis was summarized and analyzed here.

KEYWORDS

Shenfukang II capsule; IgA nephropathy; theoretical study; experimental study; clinical study

CITE THIS PAPER

Banghui Jiang, Jian Shi, Progress of Application of Shenfukang II Capsule in Iga Nephropathy. MEDS Chinese Medicine (2023) Vol. 5: 40-47. DOI: http://dx.doi.org/10.23977/medcm.2023.050706.

REFERENCES

[1] Wang Haiyan. Nephrology [J]. Chinese Journal of Medicine, 1993 (12): 714, 715.
[2] Kim Jwa-Kyung., Kim Jeong Ho., Lee Sang Choel., et al. Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clinical journal of the American Society of Nephrology: CJASN, 2012, 7(3):427-36.
[3] Suzuki Hitoshi., Kiryluk Krzysztof., Novak Jan., et al. The pathophysiology of IgA nephropathy. Journal of the American Society of Nephrology: JASN, 2011, 22(10):1795-803.
[4] Zhu Fenggui, Chen Hongyu. Professor Chen Hongyu's experience in treating IgA nephropathy [J]. Chinese Modern Doctor, 2021 Ji 59 (21): 135-138.
[5] Gou Qiang, Zheng Anmei, Luo Yong et al. Experience of Professor Zhan Huakui in staging dialectical treatment of hematuria in IgA nephropathy [J]. World Latest Medical Information Abstract, 2017, 17(68):218-219.
[6] Wang Liping, Chen Jian, Zhuang Yongze et al. Correlation analysis between blood stasis syndrome and renal pathological damage in IgA nephropathy [J]. Journal of traditional Chinese Medicine, 2009. 50 (07): 635-638.
[7] Lee H S., Choi Y., Lee J S., et al. Ultrastructural changes in IgA nephropathy in relation to histologic and clinical data. Kidney international, 1989, 35(3).
[8] Chen Xiangmei, Deng Yueyi, Xie Yuansheng. Practical guidelines for Western Medicine diagnosis and TCM Syndrome differentiation of IgA Nephropathy [J]. Chinese Journal of Integrated traditional Chinese and Western Medicine, 2013 Magazine 33 (05): 583-585.
[9] Nie Lifang. Study on TCM disease name, syndrome characteristics and treatment of tonifying qi and nourishing kidney in patients with IgA nephropathy [J]. Chinese Journal of Nephropathy of Integrated traditional Chinese and Western Medicine, 2015 Journal 16 (01): 1-3.
[10] Cheng Xiaohong, Yu Xiaoyong, Mao Jiarong. Pathological changes and TCM microscopic syndrome differentiation of IgA nephropathy [J]. Chinese Journal of Nephropathy of Integrated traditional Chinese and Western Medicine, 2014 Journal 15 (02): 185-186.
[11] Liang Heng, Xing Jianyu, Liu Xicheng, et al. Difference Protein Maps of Kidney Tissues of IgA Nephropathy Rat that Arise from the Effects of Fructus Corni [J]. Journal of Xi'an Jiaotong University, 2005, 39(6):650-655.
[12] Zhao Wushu, Zhang Yuqin, Li Jie, et al. Studies on the Immunopharmacological Effects of Japanesecornel Dogwood (Cornus officinalis) components [J]. Chinese Traditional and Herbal Drugs, 1990, 21(3):17-2046-47.
[13] Su Shanggui, Wei Yulan, Huang Yanming et al. Experimental study on the protection of kidney function in IgA nephritis by aqueous alcohol extract of Cherry fruit [J]. Shi Zhen Chinese Medicine, 2008, No. 154(06):1365-1366.
[14] Su Shanggui, Huang Yanjun, Huang Yongqi et al. Effects of flavonoids and polysaccharides from Fructus Lonicerae on the expression of TRPV5 in IgA nephropathy [J]. Medical Herald, 2016, prime35 (07): 702-705.
[15] Su Shanggui, Wei Yulan, Huang Yanming et al. Effect of Cherry blossom on renal tissue protein expression and renal function in IgA nephropathy rats [J]. Chinese Journal of Traditional Chinese Medicine, 2008(11):973-976.
[16] Lv Xiaojia, Wang Jianfen, Tang Qing et al. Effect of Jinyingzi granules and Yinyingzi slices on IgA nephritis model rats [J]. Chinese Journal of Pharmaceutical Evaluation, 2014, 31(02):86-88.
[17] Wei Yulan, Huang Yanming, Wang Kun, etc. Effect of Rosa chinensis on TGF- β gene expression in kidney tissue of rats with IgA nephropathy [J]. Shaanxi traditional Chinese Medicine, 2007 No. 311 (11): 1566-1568.
[18] Zhang Hong, Liu Nian, Li Zheng. Effect and mechanism of icariin on experimental IgA nephropathy in rats [J]. Chinese Journal of Comparative Medicine, 2017, 27 (01): 73-78.
[19] Zhao Jin, Zhu Wen. Effects of icariin on fibrosis and inflammation in IgA nephropathy rats [J]. Chinese Journal of Immunology, 2018, 34 (5) Q: 385-392.
[20] Chen Shanshan, Qi Xiangming, Zhang Wei, Wu Yonggui. Effect of tacrolimus on expression of Toll-like respectors 2 and 4 on macrophage in the kidney of early diabetic rats [J]. Chinese Pharmacological Bulletin, 2013, 29(3):377-381.
[21] Pang Xinxin, Xing Yufeng, Peng Zining, et al. A mechanism study of IgAN treatment of red peony root basedon network pharmacology and GEO data analysis [J]. Translational Medicine Journal, 2021, 10(2):70-76.
[22] Zhang Yan, Tian Yun. Research Progress on Blood Stasis Syndrome of IgA Nephropathy and Therapeutic Mechanism of Salvia miltiorrhiza [J]. Journal of Shandong University of Traditional Chinese Medicine, 2020, 44(02): 207-210.
[23] Ayikaken Kasimili, Wang Yixi, Feng Zhenfeng et al. Explore the potential mechanism of action of "Astragalus Yam" in the treatment of IgA nephropathy based on network pharmacology [J]. Review of Chinese Medicine, 2019, 29(02): 133-139.
[24] Wei Chao, Zheng Yafeng, Li Yong. Wangbuliuxing, a traditional Chinese medicine, was used to treat 18 cases of hepatitis B virus-associated renal injury [J]. Journal of Integrated traditional Chinese and Western Medicine, 2018 Journal of liver Diseases 28 (02): 119-121.
[25] Wang Ruiqi, Zhang Xiaodong, Tian Yun. Effects of ShenfukangⅡcapsule on aldosterone and intrarenal arterioles in IgAN rats [J]. Shaanxi Journal of Traditional Chinese Medicine, 2022, 43(4):421-426.
[26] Shi Jian, Liu Jianhong, Cheng Xiaohong. Effect of Shenfukang Ⅱ capsule on renal interstitial fibrosis in rats [J]. Shaanxi Journal of Traditional Chinese Medicine, 2012, 33(09):1238-1240.
[27] Liu Lu, Zhang Xiaodong, Tian Yun. Protective effects of Yishen Sanjie Huayu compound on the renal artery disease in rats with• IgA nephropathy through ERK/NF⁃κB pathway [J]. Journal of Hainan Medical University, 2021, 27(24): 1865-1871+1877.
[28] Zhao Chunwei, Tian Yun, Li Huiguang, etc. Shenfukang Ⅱ capsule in treating IgA nephropathy with tubulointerstitial fibrosis [J]. Journal of Changchun University of traditional Chinese Medicine, 2021 minute 37 (03): 558-562.
[29] Qu Kai, Yan Pei, Zhang Nan et al. Curative effect of Shenfukang Ⅱ capsule on chronic glomerulonephritis [J]. Journal of Hubei University of Traditional Chinese Medicine, 2015, 17(05):30-32.

Subscription

E-Mail Alert

Downloads:	4332
Visits:	172288

Progress of Application of Shenfukang II Capsule in Iga Nephropathy

Author(s)

Affiliation(s)

Corresponding Author

ABSTRACT

KEYWORDS

CITE THIS PAPER

REFERENCES

RESOURCES

JOIN US

PUBLICATION SERVICES

CONTACT US